LO
Cannara Biotech Inc.
LOVFF · OTC
$1.50 +3.74% (+$0.05)
1M +4.75%
Market Cap $208.4M
P/E Ratio 19.20x
Div. Yield -
ROE 10.22%
Bulios Fair Price
$1.86
24.0% upside
Current Price
$1.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LOVFF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
68 /100
Cheap EV/EBITDA 8.71x
P/S 1.77x
P/B 2.29x
Growth
100 /100
Growing Rev. growth 44.13%
Book val. growth 15.27%
EPS growth 74.83%
Profitability
60 /100
Moderate Net margin 9.22%
Op. margin 15.95%
FCF margin 4.84%
Quality
57 /100
Average ROE 10.22%
ROA 7.68%
Asset turnover 0.83x
Debt
95 /100
Low Current ratio 2.99x
Int. coverage 7.71x
Net debt/EBITDA 0.44x
Stability
44 /100
Moderate Rev. volatility 14.33%
EPS volatility 103.34%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LOVFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Zohar Krivorot
Employees
452
Headquarters
Saint-Laurent
Upcoming events
23 NOV
Earnings
Upcoming earnings report
24 NOV
Earnings
Upcoming earnings report